References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Steegen (2019) | Resistance in patients failing integrase strand transfer inhibitors: a call to replace raltegravir with dolutegravir in third-line treatment in South Africa. | Open Forum Infect Dis | IN HIV1 group M: 43 |